Literature DB >> 28654179

Exploiting the Evolutionary Relationship between Malarial Parasites and Plants To Develop New Herbicides.

Maxime G Corral1,2, Julie Leroux1,2, Stefan Tresch3, Trevor Newton3, Keith A Stubbs1, Joshua S Mylne1,2.   

Abstract

Herbicide resistance is driving a need to develop new herbicides. The evolutionary relationship between apicomplexan parasites, such as those causing malaria, and plants is close enough that many antimalarial drugs are herbicidal and so represent novel scaffolds for herbicide development. Using a compound library from the Medicines for Malaria Venture, the model plant Arabidopsis thaliana, and a physicochemical database of known herbicides, a compound was discovered that showed post-emergence herbicidal activity equal to commercial herbicides. Using structure-activity analysis, important points for its potency were found. The compound was also tested and found to be active against common crop weeds. Physiological profiling suggested the compound was a photosystem II inhibitor, representing a new scaffold for herbicide development. Overall this approach demonstrates the viability of using antimalarial compounds as lead compounds for the development of much needed new herbicides.
© 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Arabidopsis; drug discovery; herbicides; malaria

Mesh:

Substances:

Year:  2017        PMID: 28654179     DOI: 10.1002/anie.201705400

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  2 in total

1.  Inhibition of chloroplast translation as a new target for herbicides.

Authors:  Kirill V Sukhoverkov; Karen J Breese; Aleksandra W Debowski; Monika W Murcha; Keith A Stubbs; Joshua S Mylne
Journal:  RSC Chem Biol       Date:  2021-11-10

2.  Improved herbicide discovery using physico-chemical rules refined by antimalarial library screening.

Authors:  Kirill V Sukhoverkov; Maxime G Corral; Julie Leroux; Joel Haywood; Philipp Johnen; Trevor Newton; Keith A Stubbs; Joshua S Mylne
Journal:  RSC Adv       Date:  2021-02-23       Impact factor: 3.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.